Related Experiment Video
Updated: Mar 20, 2026

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
Mild Traumatic Brain Injury in Patients on Long-Term Anticoagulation Therapy: Do They Really Need Repeated Head CT
Laura Uccella1, Cesare Zoia2, Francesco Perlasca1
1Emergency Department, Ospedale di Circolo e Fondazione Macchi, Varese, Italy.
Background:
Mild traumatic brain injury (mTBI), defined as blunt trauma to the head resulting in witnessed loss of consciousness, definite amnesia, or witnessed disorientation with a Glasgow Coma Scale (GCS) score of 14 or 15 is a common occurrence in the emergency department. In mTBI, oral anticoagulation is known to be an important risk factor for hemorrhage. Clinical guidelines recommend baseline computed tomographic (CT) scan and observation for 24 hours plus a CT scan before discharge.
Methods:
We compared the non-anticoagulated and anticoagulated patients presenting at our emergency department with mTBI and no neurologic signs (GCS = 15). Every non-anticoagulated patient underwent only a baseline CT scan, whereas the anticoagulated group underwent a second CT scan after a 24-hour observation period.
Results:
Between April 2012 and April 2013, we observed 908 adult patients with mTBI and a GCS score of 15; 74 patients (8.1%) were taking oral anticoagulant drugs as long-term therapy, whereas the remaining 834 patients (91.9%) were not. In the non-anticoagulation group, 38 patients (4.6%) were positive for hemorrhage. Two patients underwent neurosurgical intervention. In the anticoagulation group, 5 patients (6.8%) were positive for hemorrhage. No patient underwent neurosurgical intervention. None of them died. The differences between the two groups were not statistically significant.
Conclusions:
Patients with a GCS score of 15 who are taking long-term anticoagulation therapy and who present with mTBI have a risk of cranial hemorrhage that is likely to be similar to that of non-anticoagulated patients. It may be reasonable to envision a protocol including only one CT scan and an appropriate observation period.
Insights
Patients on anticoagulation with mild traumatic brain injury (mTBI) have a similar cranial hemorrhage risk as those not on anticoagulation. A single CT scan may suffice, potentially reducing healthcare costs.
Area of Science:
- Emergency Medicine
- Neurology
- Radiology
Background:
- Mild traumatic brain injury (mTBI) is common in emergency departments.
- Oral anticoagulation is a known risk factor for hemorrhage in mTBI.
- Current guidelines recommend two CT scans and 24-hour observation for mTBI patients on anticoagulation.
Purpose of the Study:
- To compare cranial hemorrhage risk in anticoagulated versus non-anticoagulated patients with mTBI and a GCS score of 15.
- To evaluate the necessity of current guideline recommendations for mTBI patients on anticoagulation.
Main Methods:
- Retrospective study comparing 74 anticoagulated patients with 834 non-anticoagulated patients with mTBI (GCS=15).
- Non-anticoagulated group received one baseline CT scan.
- Anticoagulated group received a baseline CT scan and a second CT scan after 24-hour observation.
Main Results:
- Hemorrhage rates were 4.6% in non-anticoagulated and 6.8% in anticoagulated groups.
- No statistically significant difference in hemorrhage rates between groups.
- No neurosurgical interventions or deaths occurred in either group.
Conclusions:
- Anticoagulated patients with mTBI (GCS=15) have a similar cranial hemorrhage risk to non-anticoagulated patients.
- A single CT scan with appropriate observation may be sufficient for this patient group.
- This could lead to revised clinical protocols and reduced healthcare utilization.
More Related Videos
08:27Development of an Uncomplicated Mild Traumatic Brain Injury Model Modified by Weight-Drop Method and Evidenced by Magnetic Resonance Imaging
Published on: April 11, 2025
09:49Assessing Changes in Synaptic Plasticity Using an Awake Closed-Head Injury Model of Mild Traumatic Brain Injury
Published on: January 20, 2023
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management